Trial intelligence / Profile preview

Altaire Gel vs Refresh Tears in Dry Eye

NCT01382810Phase 4Unknown

Sponsor
Janssen Pharmaceutical
Start
Mar 2011
Primary completion
Oct 2012
Modality
Polymer-based Nanoparticles
Countries
1
01

Overview

A Phase 4 trial of Altaire Gel forming solution in dry eye syndrome (DED), sponsored by Janssen Pharmaceutical. Status: unknown.

02

Drugs

Altaire Gel forming solution
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT01382810.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01382810.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call